Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Droller

Showing results (201-210 of 258) with videos related to

Pageof 26
Sort By:
The Journal of Urology|September 1, 1990
Mechanisms of human bladder tumor invasion: role of protease cathepsin BR E Weiss, B C Liu, T Ahlering, et al.
The Journal of Urology|December 5, 2013
Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogateHugh J Lavery, Kristian D Stensland, Guenter Niegisch, et al.
Seminars in Urology|February 1, 1989
Treatment modalities in superficial bladder cancerR Irwin, H Zincke, M J Droller, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2016
Editorial Statement on Gleason Scoring for Prostate CancerAnthony L Zietman, Joseph Smith, Eric Klein, et al.
Urologic Oncology|May 9, 2016
New Gleason grading system: Statement from the Editors of six journalsAnthony Zietman, Joseph Smith, Eric Klein, et al.
Urology|July 1, 1989
Serum prostate-antigen levels in patients with benign prostatic hypertrophy treated with leuprolideA C Levine, A Kirschenbaum, P Kaplan, et al.
Journal of the National Cancer Institute|December 19, 2002
Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancerSteven Lehrer, Edward J Diamond, Michael J Droller, et al.
The Journal of Urology|November 21, 2002
Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasiaSteven Lehrer, Edward J Diamond, Nelson N Stone, et al.
Environmental Health Perspectives|September 6, 2005
Early environmental origins of neurodegenerative disease in later lifePhilip J Landrigan, Babasaheb Sonawane, Robert N Butler, et al.
Science (New York, N.Y.)|June 10, 1983
Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancerA P Feinberg, B Vogelstein, M J Droller, et al.
Pageof 26

Showing results (201-210 of 258) with videos related to

Sort By:
Pageof 26
The Journal of Urology|September 1, 1990
Mechanisms of human bladder tumor invasion: role of protease cathepsin BR E Weiss, B C Liu, T Ahlering, et al.
The Journal of Urology|December 5, 2013
Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogateHugh J Lavery, Kristian D Stensland, Guenter Niegisch, et al.
Seminars in Urology|February 1, 1989
Treatment modalities in superficial bladder cancerR Irwin, H Zincke, M J Droller, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2016
Editorial Statement on Gleason Scoring for Prostate CancerAnthony L Zietman, Joseph Smith, Eric Klein, et al.
Urologic Oncology|May 9, 2016
New Gleason grading system: Statement from the Editors of six journalsAnthony Zietman, Joseph Smith, Eric Klein, et al.
Urology|July 1, 1989
Serum prostate-antigen levels in patients with benign prostatic hypertrophy treated with leuprolideA C Levine, A Kirschenbaum, P Kaplan, et al.
Journal of the National Cancer Institute|December 19, 2002
Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancerSteven Lehrer, Edward J Diamond, Michael J Droller, et al.
The Journal of Urology|November 21, 2002
Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasiaSteven Lehrer, Edward J Diamond, Nelson N Stone, et al.
Environmental Health Perspectives|September 6, 2005
Early environmental origins of neurodegenerative disease in later lifePhilip J Landrigan, Babasaheb Sonawane, Robert N Butler, et al.
Science (New York, N.Y.)|June 10, 1983
Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancerA P Feinberg, B Vogelstein, M J Droller, et al.
Pageof 26